Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation
- PMID: 9267005
- DOI: 10.1099/0022-1317-78-8-2041
Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation
Abstract
Vaccinia virus (VV) produces two antigenically and structurally distinct infectious virions, intracellular mature virus (IMV) and extracellular enveloped virus (EEV). EEV is important for the efficient dissemination of virus both in vivo and in vitro where it causes formation of comet-shaped virus plaques. Here, we show that EEV, in contrast to IMV, is resistant to neutralization by antibodies bound to its surface. However, antibodies against EEV can prevent comet formation in cell culture. To explain this apparent paradox, we investigated the mechanism by which antibodies inhibit comet formation and demonstrated that antibodies prevent EEV release from infected cells, and consequently comet formation, by agglutination of the virus on the cell surface. Two complementary observations allow this conclusion: first, electron microscopy showed that infected cells incubated with medium containing anti-vaccinia virus antibodies have virus aggregates on their surface; second, culture medium from these cells contained a 4 log10 fold reduction in the physical particle/ml titre in comparison with control culture. A mechanism by which antibodies to EEV proteins provide immunological protection is thus restriction of EEV release rather than neutralization of free EEV particles.
Similar articles
-
Extracellular enveloped vaccinia virus escapes neutralization.Virology. 1996 Mar 15;217(2):478-85. doi: 10.1006/viro.1996.0142. Virology. 1996. PMID: 8610439
-
Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus.Methods Mol Biol. 2004;269:187-204. doi: 10.1385/1-59259-789-0:187. Methods Mol Biol. 2004. PMID: 15114017 Review.
-
Intracellular and extracellular vaccinia virions enter cells by different mechanisms.J Gen Virol. 1998 Apr;79 ( Pt 4):877-87. doi: 10.1099/0022-1317-79-4-877. J Gen Virol. 1998. PMID: 9568984
-
Antibody neutralization of the extracellular enveloped form of vaccinia virus.Virology. 2001 Feb 1;280(1):132-42. doi: 10.1006/viro.2000.0750. Virology. 2001. PMID: 11162827
-
Extracellular enveloped vaccinia virus. Entry, egress, and evasion.Adv Exp Med Biol. 1998;440:395-414. Adv Exp Med Biol. 1998. PMID: 9782308 Review.
Cited by
-
Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.J Virol. 2020 Sep 15;94(19):e00252-20. doi: 10.1128/JVI.00252-20. Print 2020 Sep 15. J Virol. 2020. PMID: 32699087 Free PMC article.
-
Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.J Virol. 2007 Aug;81(15):8131-9. doi: 10.1128/JVI.00374-07. Epub 2007 May 23. J Virol. 2007. PMID: 17522205 Free PMC article.
-
Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice.Viruses. 2018 Aug 26;10(9):455. doi: 10.3390/v10090455. Viruses. 2018. PMID: 30149659 Free PMC article.
-
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12.Mol Ther Oncol. 2024 Jan 10;32(1):200758. doi: 10.1016/j.omton.2023.200758. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596304 Free PMC article.
-
A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis.Mol Ther. 2013 May;21(5):1024-33. doi: 10.1038/mt.2013.27. Epub 2013 Feb 26. Mol Ther. 2013. PMID: 23439499 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources